LINDAHL RICHARD S (CIK 1196632) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-10). Recent activity: Sell EBS (3,964 shares), Buy EBS (162,680 shares), Sell EBS (23,650 shares), Sell EBS (683 shares), Sell EBS (46,155 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-10 | Emergent BioSolutions Inc. (EBS) | EVP, Chief Financial Officer | Sell | 3,964 | $31,712 |
| 2026-05-01 | Emergent BioSolutions Inc. (EBS) | EVP, Chief Financial Officer | Buy | 162,680 | $0 |
| 2026-03-05 | Emergent BioSolutions Inc. (EBS) | EVP, Chief Financial Officer | Sell | 23,650 | $199,606 |
| 2026-03-03 | Emergent BioSolutions Inc. (EBS) | EVP, Chief Financial Officer | Sell | 683 | $5,566 |
| 2026-02-10 | Emergent BioSolutions Inc. (EBS) | EVP, Chief Financial Officer | Sell | 46,155 | $504,013 |
| 2026-02-10 | Emergent BioSolutions Inc. (EBS) | EVP, Chief Financial Officer | Sell | 5,642 | $61,611 |
| 2025-10-17 | Emergent BioSolutions Inc. (EBS) | EVP, Chief Financial Officer | Sell | 4,995 | $47,952 |
| 2025-06-10 | Emergent BioSolutions Inc. (EBS) | EVP, Chief Financial Officer | Sell | 2,733 | $18,120 |
| 2025-03-10 | Emergent BioSolutions Inc. (EBS) | EVP, Chief Financial Officer | Buy | 146,888 | $0 |
| 2025-03-04 | Emergent BioSolutions Inc. (EBS) | EVP, Chief Financial Officer | Sell | 16,916 | $0 |
| 2025-03-04 | Emergent BioSolutions Inc. (EBS) | EVP, Chief Financial Officer | Sell | 1,073 | $8,026 |
| 2025-03-04 | Emergent BioSolutions Inc. (EBS) | EVP, Chief Financial Officer | Sell | 683 | $5,109 |
Source: SEC Form 4 filings · as of 2026-06-10